Regarding pharmacotherapy, Dutch standards recommend a stepwise introduction of treatments based on glycated haemoglobin (HbA1c), starting with metformin then sequentially adding sulphonylureas, followed by the addition of insulin or glucagon-like peptide-1 receptor agonists (GLP-1RAs) or dipeptidyl peptidase-4 (DPP-4) inhibitors as required to achieve and maintain glycaemic targets [9]
This is not universal, but patients should be counselled about the possibility
They are not approved by the FDA for human therapeutic use
Converting from Ozempic pen doses to compounded syringe units Patients switching from Ozempic to compounded semaglutide often need to translate their pen dose into syringe units
Every pharmacy sets its own prices, so Mounjaro might cost hundreds less per prescription at one pharmacy than it does at another
And of course, never try a new GLP-1 medication for the first time right before a race or key event thats just asking for trouble